Discover 483 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 483
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for
Cardiovascular Disease
Location: Providence RI, Brookline MA, Boston MA, Waterbury CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07000357
Phase3, Recruiting
A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumors That Are MTAP Deficient
Location: Providence RI, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06130553
Phase1, Phase2, Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
for
Heart Failure and Impaired Kidney Function
Location: Providence RI, Worcester MA, Boston MA, The Bronx NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06307652
Phase3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Providence RI, New Haven CT, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
for
Mild Cognitive Impairment, Alzheimer's Disease,
Location: East Providence RI, Toronto, Farmington Hills MI,
Sponsor: GAP Innovations, PBC
Sex: All
Age: 60 - 70+
Code: NCT06584357
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: East Providence RI, New Bedford MA, Worcester MA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
for
Alcohol Use Disorder (AUD), PTSD
Location: Providence RI
Sponsor: University of Rhode Island
Sex: All
Age: 18+
Code: NCT07217795
Recruiting
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA,
Sponsor: Moleculin Biotech, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06788756
Phase2, Phase3, Recruiting
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Providence RI, Boston MA, New York NY, Detroit MI,
Sponsor: AstraZeneca
Sex: Male
Age: 18 - 70+
Code: NCT07181161
Phase1, Phase2, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Providence RI, Hartford CT, New Haven CT,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer